期刊文献+

前列腺癌组织中VEGF-C、Bcl-xl的mRNA表达及与临床病理特征及预后的关系 被引量:5

mRNA expression of VEGF-C and Bcl-xl in prostatic carcinoma tissues and their correlation with clinical pathological characteristics and prognosis
暂未订购
导出
摘要 目的研究前列腺癌(PCa)组织中血管内皮生长因子C(VEGF-C)mRNA与B细胞淋巴瘤/白血病-xl(Bcl-xl)mRNA的表达,分析两者表达与PCa患者临床病理特征及预后的相关性。方法收集2014年1月~2016年6月广东省粤北人民医院经手术获取的132例PCa组织及40例良性前列腺增生(BPH)组织,采用实时定量PCR法检测PCa组织及BPH组织中VEGF-C mRNA、Bcl-xl mRNA的表达,分析两者表达与临床病理特征关系;采用Kaplan-Meier生存分析探究不同VEGF-C mRNA、Bcl-xl mRNA表达与患者预后的关系。结果PCa组织中VEGF-C mRNA、Bcl-xl mRNA的相对表达量均显著高于BPH组织(均P<0.05)。VEGF-C mRNA与Bcl-xl mRNA的表达呈正相关(r=0.637,P<0.05)。不同年龄、Gleason评分、入院PSA的患者PCa组织中VEGF-C mRNA、Bcl-xl mRNA表达比较,差异均无统计学意义(均P>0.05)。不同TNM分期及是否存在远处转移的的患者PCa组织中VEGF-C mRNA、Bcl-xl mRNA表达比较,差异均有统计学意义(均P<0.05)。高表达VEGF-C mRNA、Bcl-xl mRNA患者3年总体生存率分别明显低于低表达VEGF-C、Bcl-xl患者(均P<0.05)。结论PCa组织中VEGF-C mRNA、Bcl-xl mRNA表达增高与肿瘤TNM分期和是否伴有远处转移有关,VEGF-C mRNA、Bcl-xl mRNA有可能成为新的PCa诊断和治疗的生物学靶点。 Objective To study the expression of vascular endothelial growth factor C(VEGF-C)mRNA and B cell lymphoma/leukemia-xl(Bcl-xl)mRNA in prostatic carcinoma(PCa)tissues and analyze the correlation between their expressions and clinical pathological characteristics and prognosis of PCa patients.Methods One hundred and thirty-two cases of PCa and forty cases of benign prostatic hyperplasia(BPH)tissue obtained by surgery in Yuebei People's Hospital Guangdong Province from January 2014 to June 2016 were collected.Real-time quantitative PCR was used to detect the expressions of VEGF-C mRNA and Bcl-xl mRNA in PCa and BPH tissues,and the relationship between their expressions and clinical pathological characteristics was analyzed.Kaplan-meier survival analysis was used to explore the difference in prognosis of patients with different VEGF-C mRNA and Bcl-xl mRNA expressions.Results The relative expressions of VEGF-C mRNA and Bcl-xl mRNA in PCa tissues were significantly higher than those in BPH tissues(all P<0.05).The expression of VEGF-C mRNA was positively correlated with the expression of Bcl-xl mRNA(r=0.637,P<0.05).There was no significant difference in the expression of VEGF-C mRNA and Bcl-xl mRNA in PCa tissues of patients with different age,Gleason score and admission to PSA(all P>0.05).The expression of VEGF-C mRNA and Bcl-xl mRNA in PCa tissues of patients with different TNM stages and with or without distant metastasis was statistically significant(all P<0.05).The 3-year overall survival rate of patients with high expression of VEGF-C mRNA and Bcl-xl mRNA was significantly lower than that of patients with low expression of VEGF-C mRNA and Bcl-xl mRNA(all P<0.05).Conclusion The increased expression of VEGF-C mRNA and Bcl-xl mRNA in PCa tissue is related to the TNM stage of tumor and whether it is accompanied by distant metastasis.VEGF-C mRNA and Bcl-xl mRNA may become new biological targets for PCa diagnosis and treatment.
作者 韩跃辅 陈东 彭敛 黄洪才 HAN Yuefu;CHEN Dong;PENG Lian;HUANG Hongcai(The First District of Urinary Surgery,Yuebei People's Hospital,Guangdong Province,Shaoguan 512026,China)
出处 《中国医药导报》 CAS 2019年第29期96-99,103,共5页 China Medical Herald
基金 广东省自然科学基金项目(2015A03031038)
关键词 前列腺癌 VEGF-C BCL-XL 临床意义 Prostatic carcinoma Vascular endothelial growth factor C B cell lymphoma/leukemia-xl Clinical significance
  • 相关文献

参考文献6

二级参考文献33

  • 1邓君,饶绍琴,黄文芳.荧光定量PCR检测细胞周期蛋白D1对乳腺癌的诊断价值[J].实用医院临床杂志,2009,6(6):49-50. 被引量:4
  • 2沈建军,刘家云,苏明权,缪应业,张青,郝晓柯.用RNAi沉默survivin基因表达对前列腺癌细胞系PC3的影响[J].中国肿瘤生物治疗杂志,2006,13(1):37-41. 被引量:4
  • 3Krecicki T, Fraczek M, Kozlak J,et al. Bcl-xL protein expres- sion in laryngeal squamous cell carcinoma [J]. Clin Otolaryn- gol,2004,29(1 ) :55 -58.
  • 4Zhao WL, Daneshpouy ME, Mounier N,et al. Prognostic sig- nificance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma[J]. Blood, 2004,103 (2) : 695-697.
  • 5Watanabe J, Kushihata F, Honda K,et al. Prognostic significance of Bcl-xL in human hepatocellular carcinoma[J]. Surgery, 2004, 135(6) :604-612.
  • 6Ogura E, Senzaki H, Yamamoto D, et al. Prognostic signifi- cance of Bcl -2, Bcl-xL/S, Bax and Bak expressions in coloree tal carcinomas [J ]. Oncol Rep, 1999,6 (2) : 365-369.
  • 7Han HS, Park YM, Hwang TS. Differential expression of Bcl- 2, Bcl xL and p53 in eolorectal cancer [J].J Gastroenterol Hepatol,2006,21 (7) : 1 108-1 114.
  • 8Zhang YL,Pang LQ,Wu Y,et al. Significance of Bcl-xL in hu- man colon carcinoma [J]. World J Gastroenterol, 2008, 14 (19):3 069-3 073.
  • 9Espana L, Fernandez Y, Rubio N, et al. Overexpression of Bcl- xL in human breast cancer cells enhances organ-selective lymph node metastasis[J]. Breast Cancer Res Treat, 2004,87 (1) :33-44.
  • 10Weiler M, Bahr O, Hohlweg U, et al. Bcl-xL: time-dependent dissociation between modulation of apoptosis and invasiveness in human malignant glioma cells[J]. Cell Death Differ, 2006,13 (7) :1 156 -1 169.

共引文献44

同被引文献42

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部